The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Aug. 31, 2017
Applicant:

Corsens Medical Ltd., Tel Aviv, IL;

Inventor:

Alon Marmor, Kfar Hanania, IL;

Assignee:

CORSENS MEDICAL LTD., Tel Aviv, IL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/11 (2006.01); A61B 5/02 (2006.01); A61B 5/00 (2006.01); A61B 5/0452 (2006.01); G06F 19/00 (2018.01); A61B 8/08 (2006.01);
U.S. Cl.
CPC ...
A61B 5/1102 (2013.01); A61B 5/02028 (2013.01); A61B 5/0452 (2013.01); A61B 5/4824 (2013.01); A61B 5/4848 (2013.01); A61B 5/6831 (2013.01); A61B 5/7275 (2013.01); A61B 5/7278 (2013.01); A61B 5/7282 (2013.01); G06F 19/00 (2013.01); A61B 5/746 (2013.01); A61B 8/485 (2013.01); A61B 2505/01 (2013.01); A61B 2562/0204 (2013.01); A61B 2562/0219 (2013.01);
Abstract

Quantitatively determining an amount of reperfusion in an artery after angioplasty and quantitatively assessing an effectiveness of thrombolysis by non-invasively sensing from outside the subject mechanical vibrations from a mechanical contraction of at least one ventricle to simultaneously measure (a) IVCT (time duration of an isovolumetric contraction portion of a systole phase) and (b) a peak endocardial acceleration (PEA) during the IVCT. PEA is measured before and after opening the artery (or before and after thrombolysis) and in some embodiments one calculates a myocardial contractility index (MCI) of the subject, for example MCI=PEA/IVCT. A determination unit compares the first and second PEA (or the first and second MCI), and then determines an amount of reperfusion based on the comparison. The amount of reperfusion is proportionate to a viable myocardium and, in the case of thrombolysis, the amount of reperfusion quantitatively assesses the effectiveness of thrombolysis.


Find Patent Forward Citations

Loading…